[Corrigendum] Enhanced antitumor activity by the combination of dasatinib and combretastatin A‑4 in vitro and in vivo.
Saved in:
| Title: | [Corrigendum] Enhanced antitumor activity by the combination of dasatinib and combretastatin A‑4 in vitro and in vivo. |
|---|---|
| Authors: | Zhang C; School of Medicine, Zhejiang University City College, Hangzhou, Zhejiang 310015, P.R. China., Zhou SS; School of Medicine, Zhejiang University City College, Hangzhou, Zhejiang 310015, P.R. China., Li XR; School of Medicine, Zhejiang University City College, Hangzhou, Zhejiang 310015, P.R. China., Wang BM; School of Medicine, Zhejiang University City College, Hangzhou, Zhejiang 310015, P.R. China., Lin NM; Laboratory of Clinical Pharmacy, Zhejiang Cancer Hospital, Hangzhou, Zhejiang 310022, P.R. China., Feng LY; School of Medicine, Zhejiang University City College, Hangzhou, Zhejiang 310015, P.R. China., Zhang DY; School of Medicine, Zhejiang University City College, Hangzhou, Zhejiang 310015, P.R. China., Zhang LH; School of Medicine, Zhejiang University City College, Hangzhou, Zhejiang 310015, P.R. China., Wang UB; School of Medicine, Zhejiang University City College, Hangzhou, Zhejiang 310015, P.R. China., Pan JP; School of Medicine, Zhejiang University City College, Hangzhou, Zhejiang 310015, P.R. China. |
| Source: | Oncology reports [Oncol Rep] 2024 Oct; Vol. 52 (4). Date of Electronic Publication: 2024 Jul 26. |
| Publication Type: | Published Erratum |
| Journal Info: | Publisher: D.A. Spandidos Country of Publication: Greece NLM ID: 9422756 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1791-2431 (Electronic) Linking ISSN: 1021335X NLM ISO Abbreviation: Oncol Rep Subsets: MEDLINE; PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
